« Back to Record
Citation APA

Delafaille, S., Kolivras, A., Christoffersen, S., Metz, T., Bron, D., & André, J. (2013). Efficiency and cutaneous adverse effects of alemtuzumab (CAMPATH: anti-CD-52 monoclonal antibody) in a patient with T-cell prolymphocytic leukemia and erythroderma. Société Royale Belge Dermatologie et Vénérologie 2013 Abstract session presented at


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/176730

Delafaille, S., Kolivras, A., Christoffersen, S., Metz, T., Bron, D., & André, J. (2013). Efficiency and cutaneous adverse effects of alemtuzumab (CAMPATH: anti-CD-52 monoclonal antibody) in a patient with T-cell prolymphocytic leukemia and erythroderma. Société Royale Belge Dermatologie et Vénérologie 2013 Abstract session presented at